These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6812585)

  • 1. The effects of sodium valproate on gamma-aminobutyrate metabolism and behaviour in naive and ethanolamine-O-sulphate pretreated rats and mice.
    Phillips NI; Fowler LJ
    Biochem Pharmacol; 1982 Jul; 31(13):2257-61. PubMed ID: 6812585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chronic treatment with the GABA transaminase inhibitors gamma-vinyl GABA and ethanolamine O-sulphate on the in vitro GABA release from rat hippocampus.
    Qume M; Fowler LJ
    Br J Pharmacol; 1997 Oct; 122(3):539-45. PubMed ID: 9351512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of GABA, GABA-aminotransferase inhibitors and valproic acid following systemic administration in rats, cats and dogs: pharmacological approach to localize the site of action.
    Löscher W
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):32-58. PubMed ID: 6810779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sodium valproate and ethanolamine-o-sulphate on GABA metabolism in vivo [proceedings].
    Taberner PV
    Br J Pharmacol; 1979 Nov; 67(3):441P. PubMed ID: 387149
    [No Abstract]   [Full Text] [Related]  

  • 5. Adaptation of the GABAA-receptor complex in rat brain during chronic elevation of GABA by ethanolamine O-sulphate.
    Lindgren S; Simmonds MA
    Br J Pharmacol; 1987 Jul; 91(3):617-25. PubMed ID: 3038247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the pharmacology of inhibitors of GABA-metabolism.
    Löscher W
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(2):119-28. PubMed ID: 6782493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine and GABA metabolism and the anticonvulsant action of di-n-propylacetate and ethanolamine-O-sulphate.
    Horton RW; Anlezark GM; Sawaya MC; Meldrum BS
    Eur J Pharmacol; 1977 Feb; 41(4):387-97. PubMed ID: 139317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 2-aminoethanol on the synthesis, binding, uptake and metabolism of GABA.
    Löscher W
    Neurosci Lett; 1983 Dec; 42(3):293-7. PubMed ID: 6320073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant and biochemical effects of inhibitors of GABA aminotransferase and valproic acid during subchronic treatment in mice.
    Löscher W
    Biochem Pharmacol; 1982 Mar; 31(5):837-42. PubMed ID: 6805473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic administration of the GABA-transaminase inhibitor ethanolamine O-sulphate leads to up-regulation of GABA binding sites.
    Sykes C; Prestwich S; Horton R
    Biochem Pharmacol; 1984 Feb; 33(3):387-93. PubMed ID: 6322803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticonvulsant action of ethanolamine-O-sulphate and di-n-propylacetate and the metabolism of gamma-aminobutyric acid (GABA) in mice with audiogenic seizures.
    Anlezark G; Horton RW; Meldrium BS; Sawaya CB
    Biochem Pharmacol; 1976 Feb; 25(4):413-7. PubMed ID: 779794
    [No Abstract]   [Full Text] [Related]  

  • 12. A regional study of 4-aminobutyrate metabolism and amino acid levels in rat brain following chronic oral administration of ethanolamine O-sulphate.
    Fletcher A; Fowler LJ
    J Neurochem; 1982 Apr; 38(4):1022-8. PubMed ID: 7062027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of inhibitors of GABA-transaminase on hole-board exploration and on temperature. Relation with effects on quasi-morphine abstinence behaviour induced by sodium dipropylacetate.
    van der Laan JW; Weick G; van Bleek G
    Biochem Pharmacol; 1985 Nov; 34(21):3789-94. PubMed ID: 3933514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the biological activity of sodium valproate and L-lysine valproate on brain GABA levels by (3H) muscimol radioreceptor assay.
    Brunet C; Luyckx M; Bianchi A; Paluszezak D
    Farmaco Prat; 1988 Sep; 43(9):291-6. PubMed ID: 3149246
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of the gamma-aminobutyric acid neurotransmitter system in the rat cerebral cortex during repeated administration of the GABA-transaminase inhibitor ethanolamine O-sulphate.
    Sykes CC; Horton RW
    J Neurochem; 1986 Jan; 46(1):213-7. PubMed ID: 3940282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium valproate enhancement of gamma-aminobutyric acid (GABA) inhibition: electrophysiological evidence for anticonvulsant activity.
    Baldino F; Geller HM
    J Pharmacol Exp Ther; 1981 May; 217(2):445-50. PubMed ID: 6785416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of chronic treatment with the GABA transaminase inhibitors gamma-vinyl-GABA and ethanolamine-O-sulphate on the in vivo release of GABA from rat hippocampus.
    Qume M; Whitton PS; Fowler LJ
    J Neurochem; 1995 May; 64(5):2256-61. PubMed ID: 7722510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the mechanism of action of valproid acid].
    Löscher W; Frey HH
    Arzneimittelforschung; 1977; 27(5):1081-2. PubMed ID: 328017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sodium valproate (VPA) on cerebral amino acids: mechanism of gamma-aminobutyric acid (GABA) elevation and possible causal relation of VPA-induced encephalopathy and glutamine level.
    Miyazaki C; Matsuyama K; Ichikawa M; Goto S
    Chem Pharm Bull (Tokyo); 1988 Sep; 36(9):3589-94. PubMed ID: 3149216
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of anticonvulsants and gamma-aminobutyric acid (GABA)-mimetic drugs on immunoreactive somatostatin and GABA contents in the rat brain.
    Nagaki S; Kato N; Minatogawa Y; Higuchi T
    Life Sci; 1990; 46(22):1587-95. PubMed ID: 1972258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.